Skip to content

Blood Pressure and Central Vascular Stiffness in Obese Children. Relationship to Metabolic Disturbances and Subclinical Cardiovascular Damage. Effect of Weight Reduction

Blood Pressure and Central Vascular Stiffness in Obese Children. Relationship to Metabolic Disturbances and Subclinical Cardiovascular Damage. Effect of Weight Reduction

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01310088
Acronym
AORTA
Enrollment
100
Registered
2011-03-07
Start date
2011-03-31
Completion date
2013-12-31
Last updated
2011-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent, Central Blood Pressure, Children, Obesity, Subclinical Organ Damage

Keywords

Childhood, Child, adolescent, central blood pressure, ambulatory blood pressure monitoring, ABPM, clinic blood pressure, pulse wave velocity, PWV, Pulse cave analysis, PWA, heart rate variability, HRV, Echocardiography, Urine microalbuminuria, blood samples

Brief summary

The global epidemic of obesity in childhood continues to evolve and threaten future health and life expectancy primarily due to the increased incidence of cardiovascular disease. Obesity is strongly related to high blood pressure (hypertension) and both conditions pose a risk for target organ damage, which can follow a subject from childhood into adult life. The AORTA study will investigate central hemodynamics and organ damage in 100 obese children and adolescents in order to gain insight to the complex interplay of hypertension, obesity and subclinical damage in order to intensify more precise prevention, thereby reducing the future development of cardiovascular disease.

Interventions

BEHAVIORALLifestyle intervention

Treatment protocol. The Children's Obesity Clinic Department of Paediatrics Holbaek Hospital, University of Copenhagen Denmark

Sponsors

Zealand University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* age 10-18 * BMI for age and sex above 95 percentile * referred for treatment at the The Children's Obesity Clinic, Department of Paediatrics, Holbaek Hospital, University of Copenhagen * oral and written consent by their parents

Exclusion criteria

* children who can not cooperate to DEXA scanning or other procedures * linguistic difficulties that impair communication

Design outcomes

Primary

MeasureTime frameDescription
Central Blood Pressureone year follow upObtained by the SphygmoCor Device, software version 9, AtCor Medical, Australia.

Secondary

MeasureTime frameDescription
Pulse Wave velocityone year follow upMeasured in meters per second.
Ambulatory Blood Pressure Monitoring and Clinic Blood Pressureone year follow upMeasured in milimeters of mercury (mm Hg). Analysed into Blood Pressure standard deviation scores (BP SDS). Ambulatory Blood Pressure Monitoring (ABPM) is analysed into Amulatory Arterial Stiffness Index (AASI). ASSI is 1 minus the correlation coefficient when the Systolic Blood Pressure is plottet agiant the diastolic Blood Pressure from a ABPM.
Heart Rate variabilityone year follow up
Metabolic and Cardiovascular Blood Samplesone year follow up
Dual energy X-ray absorptionmetry (DEXA scan)one year follow upA full body DEXA scan gives precise knowlegde of the body fat mass and fat free mass. Fat mass can be converted into fat mass index and fat free mass can be converted into fat free mass index, besides BMI standard deviation score (BMI SDS). A DEXA scan also gives information on bone mineral density (BMD), a parameter of bone status, and regional estimates: truncus, abdomen, thorax, arms and legs.
Echocardiography and ultrasound of aortic wall distensibilityone year follow up
Electrocardiographyone year follow upConventional 12 lead electrocardiography (ECG). Analysis of: * Heart rate (beats per minute) * P waves, QRS waves, ST segment and T waves (durations: miliseconds, amplitude: milimeters/Voltage) * Intervals: PQ, PR, QRS, ST, T waves (miliseconds) * Configuration of the T wave.
Anthropometric measuresone year follow upHeight, Waist, Weight, BMI (weight/height²)
Urine Albumine-Creatinine Ratio (UACR)one year follow upMicroalbuminuria (MAU) defined by urine albumine-creatinine ratio (UACR) ≥ 3,5 mg/mmol (women) and 2,5 mg/mmol (men). Mean of two morning spot urine samples.

Countries

Denmark

Contacts

Primary ContactKristian Hvidt, MD
krhv@regionsjaelland.dk0014559484073

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026